Cargando…
Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
BACKGROUNDS: Myasthenia Gravis (MG), a chronic neuromuscular junction disorder, emerged as one of the serious side effects of the Coronavirus Disease 2019 (COVID-19) vaccination. We aimed to summarize the findings of studies on the clinical features and outcomes of COVID-19 vaccination-associated MG...
Autores principales: | Tayebi, Amir Hossein, Samimisedeh, Parham, Jafari Afshar, Elmira, Ayati, Aryan, Ghalehnovi, Elaheh, Foroutani, Laleh, Abbasi Khoshsirat, Nahid, Rastad, Hadith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553155/ https://www.ncbi.nlm.nih.gov/pubmed/37800781 http://dx.doi.org/10.1097/MD.0000000000034890 |
Ejemplares similares
-
Efficacy and safety of intracoronary epinephrine for the management
of the no-reflow phenomenon following percutaneous coronary interventions: a
systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023) -
Prognostic factors for conversion to generalization in ocular myasthenia gravis
por: Witthayaweerasak, Juthamat, et al.
Publicado: (2021) -
Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis
por: Weng, Yi-Yun, et al.
Publicado: (2016) -
Facial-onset sensory and motor neuronopathy with myasthenia gravis: A case report
por: Pan, Chengyu, et al.
Publicado: (2023) -
TNFAIP3 gene rs7749323 polymorphism is associated with late onset myasthenia gravis
por: Yang, Hong-Wei, et al.
Publicado: (2017)